Answer
Women of childbearing potential should use effective contraception during lazertinib treatment and up to 3 weeks after treatment.
Sources for this answer
- Lazcluze 80 mg film-coated tabletsJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 3Document updated
Sources checked